No Prescription |
 |
 | ||
|
Fluzole Diflucan |
|
| ||
No Prescription » Prescription Drugs 8 » Fluzole Diflucan Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Fluconazole is used for: Treating and preventing certain yeast and fungal infections. Fluconazole is an antifungal antibiotic. Fluconazole is used to treat infections caused by fungus which can invade any part of the body including the mouth throat esophagus lungs bladder genital area and the blood. Fluconazole is also used to prevent fungal infection in people with weak immune systems caused by cancer treatment bone marrow transplant or diseases such as AIDS. Fluconazole is used to treat fungal infections called candidiasis (also known as thrush or yeast infections). These include vaginal infections throat infections and fungal infections elsewhere in the body such as infections of the urinary tract peritonitis (inflammation of the lining of the abdomen) and pneumonia. Fluconazole is also prescribed to guard against candidiasis in some people receiving bone marrow transplants and is used to treat meningitis (brain or spinal cord inflammation) caused by another type of fungus. In addition Fluconazole is now being prescribed for fungal infections in kidney and liver transplant patients and fungal infections in patients with AIDS. Buy Fluzole Diflucan and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Fluzole Diflucan: Product Type: Prescription Drugs 8 Fluzole ( Diflucan Generic Fluconazole ) Fluzole (Diflucan Generic Fluconazole) Diflucan Generic Fluconazole 150mg 15 ( 1 x 15 )Caps 150mg 7 ( 1 x 7 ) Caps 50mg 84( 12 x 7 ) Caps 50mg 21 ( 3 x 7 ) Caps 50mg 42 ( 6 x 7 ) Caps Diflucan Generic Fluconazole Fluzole
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
